Neurotoxic species in prion disease: A role for PrP isoforms?

Journal of Neurochemistry

Volumn 103, Issue 5, 2007, Pages 1709-1720

  Harrison, Christopher F ^a   Barnham, Kevin J ^a,b   Hill, Andrew F ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

ctmPrP; Creutzfeldt Jakob disease; Prion; Protein biogenesis; Transmembrane domain; Transmissible spongiform encephalopathy

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; ISOPROTEIN; MEMBRANE PROTEIN; PRION PROTEIN;

ALZHEIMER DISEASE; ATAXIA; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; EXPERIMENTAL MODEL; GLIOSIS; HUMAN; HYDROPHOBICITY; LIPID BILAYER; MEDICAL RESEARCH; MICROSOME MEMBRANE; MOLECULAR DYNAMICS; MUTATION; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARESIS; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SYNTHESIS; REVIEW; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MODELS, BIOLOGICAL; NEUROTOXINS; PRION DISEASES; PROTEIN ISOFORMS; PRPC PROTEINS; PRPSC PROTEINS;

BOS; BOVINAE;

EID: 36248957603     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04936.x     Document Type: Review

References (110)

1. Armendariz A. D., Gonzalez M., Loguinov A. V. Vulpe C. D. (2004) Gene expression profiling in chronic copper overload reveals upregulation of Prnp and APP. Physiol Genomics 20, 45 54.
2. Barnham K. J., Cappai R., Beyreuther K., Masters C. L. Hill A. F. (2006) Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem. Sci. 31, 465 472.
3. Baumann F., Tolnay M., Brabeck C. et al. (2007) Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 26, 538 547.
4. Bazan J. F., Fletterick R. J., McKinley M. P. Prusiner S. B. (1987) Predicted secondary structure and membrane topology of the scrapie prion protein. Protein Eng. 1, 125 135.
5. Bolton D., McKinley M. Prusiner S. (1982) Identification of a protein that purifies with the scrapie prion. Science 218, 1309 1311.
6. Borchelt D. R., Scott M., Taraboulos A., Stahl N. Prusiner S. B. (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J. Cell Biol. 110, 743 752.
7. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C. Aguzzi A. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339 343.
8. Brazier M. W., Lewis V., Ciccotosto G. D. et al. (2006) Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease. Brain Res. Bull. 68, 346 354.
9. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H. P., DeArmond S. J., Prusiner S. B., Aguet M. Weissmann C. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577 582.
10. Bueler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M. Weissmann C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339 1347.
11. Castilla J., Saa P., Hetz C. Soto C. (2005a) In vitro generation of infectious scrapie prions. Cell 121, 195 206.
12. Castilla J., Saa P. Soto C. (2005b) Detection of prions in blood. Nat. Med. 11, 982 985.
13. Caughey B. Lansbury P. T. (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267 298.
14. Chabry J., Caughey B. Chesebro B. (1998) Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J. Biol. Chem. 273, 13203 13207.
15. Chabry J., Ratsimanohatra C., Sponne I., Elena P. P., Vincent J. P. Pillot T. (2003) In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression. J. Neurosci. 23, 462 469.
16. Chesebro B., Race R., Wehrly K. et al. (1985) Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315, 331 333.
17. Chesebro B., Wehrly K., Caughey B., Nishio J., Ernst D. Race R. (1993) Foreign PrP expression and scrapie infection in tissue culture cell lines. Dev. Biol. Stand. 80, 131 140.
18. Chesebro B., Trifilo M., Race R. et al. (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435 1439.
19. Chiesa R., Piccardo P., Quaglio E., Drisaldi B., Si-Hoe S. L., Takao M., Ghetti B. Harris D. A. (2003) Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol. 77, 7611 7622.
20. Choi J. K., Park S. J., Jun Y. C., Oh J. M., Jeong B. H., Lee H. P., Park S. N., Carp R. I. Kim Y. S. (2006) Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein. Hybridoma (Larchmt) 25, 271 277.
21. Cohen F. E. Prusiner S. B. (1998) Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67, 793 819.
22. Cohen F. E., Pan K. M., Huang Z., Baldwin M., Fletterick R. J. Prusiner S. B. (1994) Structural clues to prion replication. Science 264, 530 531.
23. Collinge J., Whittington M. A., Sidle K. C., Smith C. J., Palmer M. S., Clarke A. R. Jefferys J. G. (1994) Prion protein is necessary for normal synaptic function. Nature 370, 295 297.
24. De Fea K. A., Nakahara D. H., Calayag M. C., Yost C. S., Mirels L. F., Prusiner S. B. Lingappa V. R. (1994) Determinants of carboxyl-terminal domain translocation during prion protein biogenesis. J. Biol. Chem. 269, 16810 16820.
25. Deleault N. R., Lucassen R. W. Supattapone S. (2003) RNA molecules stimulate prion protein conversion. Nature 425, 717 720.
26. Deleault N. R., Harris B. T., Rees J. R. Supattapone S. (2007) From the Cover: formation of native prions from minimal components in vitro. Proc. Natl Acad. Sci. USA 104, 9741 9746.
27. Diaz-Nido J., Wandosell F. Avila J. (2002) Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides 23, 1323 1332.
28. Doh-ura K., Tateishi J., Sasaki H., Kitamoto T. Sakaki Y. (1989) Pro→leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome. Biochem. Biophys. Res. Commun. 163, 974 979.
29. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H. Raposo G. (2004) Cells release prions in association with exosomes. Proc. Natl Acad. Sci. USA 101, 9683 9688.
30. Fioriti L., Dossena S., Stewart L. R., Stewart R. S., Harris D. A., Forloni G. Chiesa R. (2005) Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J. Biol. Chem. 280, 11320 11328.
31. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A. Weissmann C. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255 1264.
32. Fons R. D., Bogert B. A. Hegde R. S. (2003) Substrate-specific function of the translocon-associated protein complex during translocation across the ER membrane. J. Cell Biol. 160, 529 539.
33. Grenier C., Bissonnette C., Volkov L. Roucou X. (2006) Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells. J. Neurochem. 97, 1456 1466.
34. Gu Y., Verghese S., Mishra R. S., Xu X., Shi Y. Singh N. (2003) Mutant prion protein-mediated aggregation of normal prion protein in the endoplasmic reticulum: implications for prion propagation and neurotoxicity. J. Neurochem. 84, 10 22.
35. Gu Y., Luo X., Basu S., Fujioka H. Singh N. (2006) Cell-specific metabolism and pathogenesis of transmembrane prion protein. Mol. Cell. Biol. 26, 2697 2715.
36. Haass C. Selkoe D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101 112.
37. Hay B., Barry R. A., Lieberburg I., Prusiner S. B. Lingappa V. R. (1987) Biogenesis and transmembrane orientation of the cellular isoform of the scrapie prion protein published errratum appears in Mol. Cell Biol. 1987, 7(5), 2035 Mol. Cell. Biol. 7, 914 920.
38. Hegde R. S., Mastrianni J. A., Scott M. R., DeFea K. A., Tremblay P., Torchia M., DeArmond S. J., Prusiner S. B. Lingappa V. R. (1998a) A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827 834.
39. Hegde R. S., Voigt S. Lingappa V. R. (1998b) Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol. Cell 2, 85 91.
40. Hegde R. S., Tremblay P., Groth D., DeArmond S. J., Prusiner S. B. Lingappa V. R. (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402, 822 826.
41. von Heijne G. (1985) Signal sequences. The limits of variation. J. Mol. Biol. 184, 99 105.
42. Henry C. Knight R. (2002) Clinical features of variant Creutzfeldt-Jakob disease. Rev. Med. Virol. 12, 143 150.
43. Hill A. F., Antoniou M. Collinge J 1999) Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80 (Pt. 1 11 14.
44. Hill A. F., Joiner S., Linehan J., Desbruslais M., Lantos P. L. Collinge J. (2000) Species-barrier-independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 97, 10248 10253.
45. Hill A. F., Joiner S., Wadsworth J. D., Sidle K. C., Bell J. E., Budka H., Ironside J. W. Collinge J. (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126, 1333 1346.
46. Hitt A. L., Lu T. H. Luna E. J. (1994) Ponticulin is an atypical membrane protein. J. Cell Biol. 126, 1421 1431.
47. Holada K., Simak J., Risitano A. M., Maciejewski J., Young N. S. Vostal J. G. (2002) Activated platelets of patients with paroxysmal nocturnal hemoglobinuria express cellular prion protein. Blood 100, 341 343.
48. Holme A., Daniels M., Sassoon J. Brown D. R. (2003) A novel method of generating neuronal cell lines from gene-knockout mice to study prion protein membrane orientation. Eur. J. Neurosci. 18, 571 579.
49. Ivanova L., Barmada S., Kummer T. Harris D. A. (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J. Biol. Chem. 276, 42409 42421.
50. Jarrett J. T. Lansbury P. T. Jr. (1993) Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055 1058.
51. Kang S. W., Rane N. S., Kim S. J., Garrison J. L., Taunton J. Hegde R. S. (2006) Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway. Cell 127, 999 1013.
52. Kim S. J. Hegde R. S. (2002) Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel. Mol. Biol. Cell 13, 3775 3786.
53. Kim S. J., Rahbar R. Hegde R. S. (2001) Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain. J. Biol. Chem. 276, 26132 26140.
54. Kimberlin R. H. Walker C. A. (1978) Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J. Gen. Virol. 39, 487 496.
55. Koster B. Strand M. (1994) Schistosoma mansoni: Sm23 is a transmembrane protein that also contains a glycosylphosphatidylinositol anchor. Arch. Biochem. Biophys. 310, 108 117.
56. Kristiansen M., Deriziotis P., Dimcheff D. E. et al. (2007) Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol. Cell 26, 175 188.
57. Kurschner C. Morgan J. I. (1995) The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res. 30, 165 168.
58. Legname G., Baskakov I. V., Nguyen H. O., Riesner D., Cohen F. E., DeArmond S. J. Prusiner S. B. (2004) Synthetic mammalian prions. Science 305, 673 676.
59. Li A. Harris D. A. (2005) Mammalian prion protein suppresses Bax-induced cell death in yeast. J. Biol. Chem. 280, 17430 17434.
60. Li A., Christensen H. M., Stewart L. R., Roth K. A., Chiesa R. Harris D. A. (2007) Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J. 26, 548 558.
61. Lopez C. D., Yost C. S., Prusiner S. B., Myers R. M. Lingappa V. R. (1990) Unusual topogenic sequence directs prion protein biogenesis. Science 248, 226 229.
62. Ma J., Wollmann R. Lindquist S. (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781 1785.
63. Mallucci G., Dickinson A., Linehan J., Klohn P. C., Brandner S. Collinge J. (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871 874.
64. Manson J. C., Jamieson E., Baybutt H. et al. (1999) A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J. 18, 6855 6864.
65. McGowan J. (1922) Scrapie in sheep. Scott. J. Agric. 5, 365 375.
66. Mead S. (2006) Prion disease genetics. Eur. J. Hum. Genet. 14, 273 281.
67. Merz P. A., Somerville R. A., Wisniewski H. M. Iqbal K. (1981) Abnormal fibrils from scrapie-infected brain. Acta Neuropathol. (Berl.) 54, 63 74.
68. Mishra R. S., Gu Y., Bose S., Verghese S., Kalepu S. Singh N. (2002) Cell surface accumulation of a truncated transmembrane prion protein in Gerstmann-Straussler-Scheinker disease P102L. J. Biol. Chem. 277, 24554 24561.
69. Miyauchi K., Komano J., Yokomaku Y., Sugiura W., Yamamoto N. Matsuda Z. (2005) Role of the specific amino Acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J. Virol. 79, 4720 4729.
70. Moore R. C., Lee I. Y., Silverman G. L. et al. (1999) Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein Doppel. J. Mol. Biol. 292, 797 817.
71. Moore R. C., Mastrangelo P., Bouzamondo E. et al. (2001) Doppel-induced cerebellar degeneration in transgenic mice. Proc. Natl Acad. Sci. USA 98, 15288 15293.
72. Naslavsky N., Stein R., Yanai A., Friedlander G. Taraboulos A. (1997) Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J. Biol. Chem. 272, 6324 6331.
73. Novitskaya V., Bocharova O. V., Bronstein I. Baskakov I. V. (2006) Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J. Biol. Chem. 281, 13828 13836.
74. Osborne A. R., Rapoport T. A. van den Berg B. (2005) Protein translocation by the Sec61/SecY channel. Annu. Rev. Cell Dev. Biol. 21, 529 550.
75. Ott C. M. Lingappa V. R. (2004) Signal sequences influence membrane integration of the prion protein. Biochemistry 43, 11973 11982.
76. Ott C. M., Akhavan A. Lingappa V. R. (2007) Specific features of the prion protein transmembrane domain regulate nascent chain orientation. J. Biol. Chem. 282, 11163 11171.
77. Ou D. M., Chen C. C. Chen C. M. (2007) Contact-induced structure transformation in transmembrane prion propagation. Biophys. J. 92, 2704 2710.
78. Pan K. M., Baldwin M., Nguyen J. et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA 90, 10962 10966.
79. Panegyres P. K., Toufexis K., Kakulas B. A., Cernevakova L., Brown P., Ghetti B., Piccardo P. Dlouhy S. R. (2001) A new PRNP mutation (G131V) associated with Gerstmann-Straussler-Scheinker disease. Arch. Neurol. 58, 1899 1902.
80. Pauly P. C. Harris D. A. (1998) Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107 33110.
81. Peretz D., Williamson R. A., Matsunaga Y. et al. (1997) A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273, 614 622.
82. Piccardo P., Manson J. C., King D., Ghetti B. Barron R. M. (2007) Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc. Natl Acad. Sci. USA 104, 4712 4717.
83. Pillot T., Lins L., Goethals M., Vanloo B., Baert J., Vandekerckhove J., Rosseneu M. Brasseur R. (1997) The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion. J. Mol. Biol. 274, 381 393.
84. Pillot T., Drouet B., Pincon-Raymond M., Vandekerckhove J., Rosseneu M. Chambaz J. (2000) A nonfibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat cortical neurons. J. Neurochem. 75, 2298 2308.
85. Rambold A. S., Miesbauer M., Rapaport D., Bartke T., Baier M., Winklhofer K. F. Tatzelt J. (2006) Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. Mol. Biol. Cell 17, 3356 3368.
86. Rane N. S., Yonkovich J. L. Hegde R. S. (2004) Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J. 23, 4550 4559.
87. Richt J. A., Kasinathan P., Hamir A. N. et al. (2007) Production of cattle lacking prion protein. Nat. Biotechnol. 25, 132 138.
88. Rodriguez M. M., Peoc'h K., Haik S. et al. (2005) A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology 64, 1455 1457.
89. Russ W. P. Engelman D. M. (2000) The GxxxG motif: a framework for transmembrane helix-helix association. J. Mol. Biol. 296, 911 919.
90. Rutkowski D. T., Lingappa V. R. Hegde R. S. (2001) Substrate-specific regulation of the ribosome-translocon junction by N-terminal signal sequences. Proc. Natl Acad. Sci. USA 98, 7823 7828.
91. Rutkowski D. T., Ott C. M., Polansky J. R. Lingappa V. R. (2003) Signal sequences initiate the pathway of maturation in the endoplasmic reticulum lumen. J. Biol. Chem. 278, 30365 30372.
92. Schatzl H. M., Da Costa M., Taylor L., Cohen F. E. Prusiner S. B. (1995) Prion protein gene variation among primates. J. Mol. Biol. 245, 362 374.
93. Shan S. O. Walter P. (2005) Co-translational protein targeting by the signal recognition particle. FEBS Lett. 579, 921 926.
94. Shyng S. L., Huber M. T. Harris D. A. (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J. Biol. Chem. 268, 15922 15928.
95. Smith S. O., Song D., Shekar S., Groesbeek M., Ziliox M. Aimoto S. (2001) Structure of the transmembrane dimer interface of glycophorin A in membrane bilayers. Biochemistry 40, 6553 6558.
96. Solforosi L., Criado J. R., McGavern D. B. et al. (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514 1516.
97. Stewart R. S. Harris D. A. (2001) Most pathogenic mutations do not alter the membrane topology of the prion protein. J. Biol. Chem. 276, 2212 2220.
98. Stewart R. S. Harris D. A. (2003) Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J. Biol. Chem. 278, 45960 45968.
99. Stewart R. S. Harris D. A. (2005) A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons. J. Biol. Chem. 280, 15855 15864.
100. Stewart R. S., Drisaldi B. Harris D. A. (2001) A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum. Mol. Biol. Cell 12, 881 889.
101. Stewart R. S., Piccardo P., Ghetti B. Harris D. A. (2005) Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J. Neurosci. 25, 3469 3477.
102. Tateishi J. Kitamoto T. (1995) Inherited prion diseases and transmission to rodents. Brain Pathol. 5, 53 59.
103. Thery C., Zitvogel L. Amigorena S. (2002) Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569 579.
104. Trifilo M. J., Yajima T., Gu Y. et al. (2006) Prion-induced amyloid heart disease with high blood infectivity in transgenic mice. Science 313, 94 97.
105. Vella L. J., Sharples R. A., Lawson V. A., Masters C. L., Cappai R. Hill A. F. (2007) Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J. Pathol. 211, 582 590.
106. Vilette D., Andreoletti O., Archer F., Madelaine M. F., Vilotte J. L., Lehmann S. Laude H. (2001) Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl Acad. Sci. USA 98, 4055 4059.
107. Voigt S., Jungnickel B., Hartmann E. Rapoport T. A. (1996) Signal sequence-dependent function of the TRAM protein during early phases of protein transport across the endoplasmic reticulum membrane. J. Cell Biol. 134, 25 35.
108. Walsh D. M., Klyubin I., Shankar G. M. et al. (2005) The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochem. Soc. Trans. 33, 1087 1090.
109. Williams E. S. Young S. (1980) Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J. Wildl. Dis. 16, 89 98.
110. Yost C. S., Lopez C. D., Prusiner S. B., Myers R. M. Lingappa V. R. (1990) Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 343, 669 672.